Advertisement

Diagnostic Adjuncts for Screening and Surveillance in Head and Neck Cancer

  • James MurphyEmail author
  • Mohammed Qaisi
Chapter
First Online:
  • 268 Downloads

Abstract

Head and neck cancers tend to be diagnosed at a late stage. This has prognostic implications for the patient. Research interest has been directed to developing diagnostic and screening adjuncts that would facilitate earlier diagnosis of this condition. Adjuncts include vital staining, visual light-based adjuncts, exfoliative-based techniques, molecular biology, and in vivo microscopy. These will be discussed in this chapter. Although these techniques have not been shown to be as effective as a thorough clinical oral examination, they remain as an area of interest and active research.

Keywords

Toludine blue Lugol’s iodine Chemiluminescence Tissue fluorescence imaging Brush biopsy DNA-image cytometry Molecular biology In vivo microscopy 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgement

The authors have no conflict of interest to declare.

References

  1. 1.
    WHO. World cancer report 2014. Geneva: World Health Organization; 2014.Google Scholar
  2. 2.
    AJCC. AJCC cancer staging manual. 8th ed. New York, NY: Springer; 2016.Google Scholar
  3. 3.
    Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, Rajan B, Trivandrum Oral Cancer Screening Study Group. Effects of screening on oral cancer mortality in Kerala, India: a cluster randomized controlled trial. Lancet. 2005;365:1927–33.PubMedCrossRefGoogle Scholar
  4. 4.
    Holmes JD, Dierks EJ, Homer LD, Potter BE. Is detection of oral and oropharyngeal squamous cell cancer by a dental care provider associated with a lower stage at diagnosis. J Oral Maxillofac Surg. 2003;61:285–91.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/oral-cancer-screening1.Google Scholar
  6. 6.
    https://www.aafp.org/patient-care/clinical-recommendations/all/oral-cancer.html.Google Scholar
  7. 7.
    American Cancer Society. American Cancer Society guidelines for the early detection of cancer. Atlanta, GA: American Cancer Society; 2013. Accessed at http://www.cancer.org/healthy/findcancerearly/cancerscreeningguidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer.Google Scholar
  8. 8.
    Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010;141(5):509–20.PubMedCrossRefGoogle Scholar
  9. 9.
    Lee JJ, Hung HC, Cheng SJ, Chiang CP, Liu BY, Yu CH, Jeng JH, Chang HH, Kok SH. Factors associated with underdiagnosis from incisional biopsy of oral leukoplakic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:217–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Abbey LM, Kaugars GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA, Eisenberg E, Krutchkoff DJ, Cushing M. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:188–91.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol. 1989;67:621–7.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Warnakulasuriya KA, Johnson NW. Sensitivity and specificity of Orascan® toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med. 1996;25:97–103.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:535–40.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Epstein JB, Güneri P. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg. 2009;17:79–87.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Awan K, Yang Y, Morgan P, Warnakulasuriya S. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity—a clinical and histological assessment. Oral Dis. 2012;18:728–33.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Awadallah M, Idle M, Patel K, Kademani D. Management update of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:628–36.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    McMahon J, Devine JC, McCaul JA, McLellan DR, Farrow A. Use of Lugol’s iodine in the resection of oral and oropharyngeal squamous cell carcinoma. Br J Oral Maxillofac Surg. 2010;48:84–7.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Petruzzi M, Lucchese A, Baldoni E, Grassi FR, Serpico R. Use of Lugol’s iodine in oral cancer diagnosis: an overview. Oral Oncol. 2010;46:811–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Epstein JB, Scully C, Spinelli J. Toluidine blue and Lugol’s iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med. 1992;21:160–3.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Rashid A, Warnakulasuriya S. The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review. J Oral Pathol Med. 2015;44:307–28.CrossRefGoogle Scholar
  21. 21.
    Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44:10–22.PubMedCrossRefGoogle Scholar
  22. 22.
    Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, Shukla P. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc. 2010;141:151–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Epstein JB, Gorsky M, Lonky S, Silverman S Jr, Epstein JD, Bride M. The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dentist. 2006;26:171–4.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg. 2007;65:424–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Huber MA. Adjunctive diagnostic techniques for oral and oropharyngeal cancer discovery. Dent Clin N Am. 2018;62:59–75.PubMedCrossRefGoogle Scholar
  26. 26.
    Bhatia N, Matias MAT, Farah CS. Assessment of a decision making protocol to improve the efficacy of VELscope™ in general dental practice: a prospective evaluation. Oral Oncol. 2014;50:1012–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Poh CF, Anderson DW, Durham JS, Chen J, Berean KW, MacAulay CE, Rosin MP. Fluorescence visualization-guided surgery for early-stage oral cancer. JAMA Otolaryngol Head Neck Surg. 2016;142:209–16.PubMedCrossRefGoogle Scholar
  28. 28.
    Leston JS, Dios PD. Diagnostic clinical aids in oral cancer. Oral Oncol. 2010;46:418–22.CrossRefGoogle Scholar
  29. 29.
    Awan KH, Morgan PR, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol. 2011;47:274–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A. Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res. 2008;14:2396–404.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy US Collaborative OralCDx Study Group. J Am Dent Assoc. 1999;130:1445–57.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Eisen D. Brush biopsy ‘saves lives’. J Am Dent Assoc. 2002;133:688.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Sciubba JJ. Brush biopsy ‘bridges the gap’. J Am Dent Assoc. 2002;133:692.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Farran H. Overwhelmingly positive. J Am Dent Assoc. 2002;133:692.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examination and lesion diagnosis. A systematic review of the literature. JADA. 2008;139:896–905.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Macey R, Walsh T, Brocklehurst P, Kerr AR, Liu JL, Lingen MW, Ogden GR, Warnakulasuriya S, Scully C. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2015;5:CD010276.Google Scholar
  37. 37.
    Kämmerer PW, Koch FP, Santoro M, Babaryka G, Biesterfeld S, Brieger J, Kunkel M. Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy. Oral Oncol. 2013;49:420–6.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Ye X, Zhang J, Tan Y, Chen G, Zhou G. Meta-analysis of two computer-assisted screening methods for diagnosing oral precancer and cancer. Oral Oncol. 2015;51:966–75.PubMedCrossRefGoogle Scholar
  39. 39.
    Cheng YS, Rees T, Wright J. A review of research on salivary biomarkers for oral cancer detection. Clin Transl Med. 2014;3:3.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Kaur J, Jacobs R, Huang Y, Salvo N, Politis C. Salivary biomarkers for oral cancer and pre-cancer screening: a review. Clin Oral Investig. 2018;22:633–40.PubMedCrossRefGoogle Scholar
  41. 41.
    Graveland AP, Bremmer JF, de Maaker M, Brink A, Cobussen P, Zwart M, Braakhuis BJ, Bloemena E, van der Waal I, Leemans CR, Brakenhoff RH. Molecular screening of oral precancer. Oral Oncol. 2013;49:1129–35.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Yang EC, Tan MT, Schwarz RA, Richards-Kortum RR, Gillenwater AM, Vigneswaran N. Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:670–81.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Adhi M, Duker JS. Optical coherence tomography – current and future applications. Curr Opin Ophthalmol. 2013;24:213–21.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Lingen MW, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D’Souza G, Gurenlian J, Kalmar JR, Kerr AR, Lambert PM, Patton LL, Sollecito TP, Truelove E, Tampi MP, Urquhart O, Banfield L, Carrasco-Labra A. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American Dental Association. J Am Dent Assoc. 2017;148:712–27.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    https://www.ahns.info/wp-content/uploads/2017/05/Early-Detection-of-Pre-Malignant-Oral-Cancer-FINAL.pdf.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Oral and Maxillofacial Surgery, Department of SurgeryJohn H. Stroger, Jr. Hospital of Cook CountyChicagoUSA

Personalised recommendations

Cite chapter

Buy options